about
Modafinil for the treatment of cocaine dependenceA double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patientsA double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patientsTopiramate for treating alcohol dependence: a randomized controlled trial.Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial.Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkersThe efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression.Quetiapine for treatment of alcohol dependence.Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned.Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependenceClinicians on the front line: active management of depression and anxiety in primary care.Effect of five-consecutive-day exposure to an anxiogenic stressor on sleep-wake activity in ratsEffects of low dose cocaine on REM sleep in the freely moving rat.Relationship between medication adherence and treatment outcomes: the COMBINE study.Differences between daily smokers, chippers, and nonsmokers with co-occurring anxiety and alcohol-use disordersDeep brain stimulation of the nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug seeking in ratsCombined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.A Gompertz age-specific mortality rate model of aging, hormesis, and toxicity: fixed-dose studies.Yoga Asana sessions increase brain GABA levels: a pilot study.Dexamethasone suppression test in recently detoxified alcoholics: clinical implications.Zonisamide decreases ethanol intake in rats and mice.Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study.Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.Alprazolam and benzodiazepine dependence.Fatal hyperthermia following haloperidol therapy of sedative-hypnotic withdrawal.Alcoholism and mortality kinetics.Deep brain stimulation of the nucleus accumbens reduces ethanol consumption in rats.Reduced Plasma Nitric Oxide End Products in Cocaine-dependent Men.A benzodiazepine mood effect scale: reliability and validity determined for alcohol-dependent subjects and adults with a parental history of alcoholism.The relationship of alprazolam dose to steady-state plasma concentrations.Adenosine agonists CGS 21680 and NECA inhibit the initiation of cocaine self-administration.Additive effects of intra-accumbens infusion of the cAMP-specific phosphodiesterase inhibitor, rolipram and cocaine on brain stimulation reward.Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder.Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects.An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder.Safety and efficacy of GABAergic medications for treating alcoholism.White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects.On guidelines for maximum dosages.
P50
Q24652419-F39A702C-F2B7-495E-B677-C6FAF4233108Q30417813-D6093682-926F-4261-865F-5651F51E7E8EQ30422068-C0ECEE3C-FD41-4389-B77B-27F0B4E5C766Q30444701-5003E6B6-3849-42CA-903A-53F3EB95A51EQ30446318-B1CD79A5-3471-46CD-83AB-3E9E0E593002Q30983518-A7B548AC-6B4F-4F49-99F3-30091A4E3A47Q33637610-19F60252-5F42-4DFB-91D0-C91FBBEEB67AQ34119362-3A8B3C58-639F-4665-84B3-DAE9666249AFQ35878627-EBFE9419-5109-44CC-A008-6C0923B3D6F1Q36054006-6E01ACF7-93CA-4F4A-A08A-AB4B70C91C27Q36341608-E3F7ECD1-1F62-4C6D-A9F5-6384A218B835Q36603109-6D6B9665-EBD8-4470-B458-D0C66566348FQ36636885-314B89ED-2229-4406-9EDE-D68937E991D0Q36731102-14C12D25-613A-4E4E-A18B-8FFF476C68D3Q36952204-0C66F9CA-AD61-4B88-BBBC-0EE5CA2F8123Q36963864-11EA0EF0-391D-4EAB-A46A-8E767E59F7AFQ36978517-2DBC2132-4140-4465-9DED-3A6DBB3A27D0Q38407349-FA51C79D-3DC5-467B-B011-1FF946C765F8Q38453119-7B97F80C-D0C8-4F02-B20E-E39C958CFF59Q39564013-E2C63345-7524-484D-A7A8-4027331380AAQ40209150-280FB3A5-0FFC-4DA5-A47D-A0CC2B4DE5C9Q40239101-BCFA9D4D-8399-43F3-B7B2-A35DB13BB2B6Q40469992-A7B02883-0A48-4184-B2A1-8D4F5D1EC753Q40511573-4DFBF4D1-0D5A-41DF-BCDB-089B8EE8CC8EQ40791736-56D55E02-316D-4885-90FE-CE03DCCF499CQ40791749-7F23DFDE-D3D6-4EC0-90E9-2D355DD929A9Q40874392-8F61F9DD-5C1C-49B7-9C95-F2DBF8C1312BQ41420575-33B68425-1E41-4A41-97A6-939A73560361Q41999212-7CE6864D-AE3A-4118-BC1B-9FFAD7531180Q42730450-BC4D4EAD-0F60-4DD1-9D26-6A100891A753Q43647642-63F34B13-BCC6-424A-B6EE-8AAD7E5AA583Q43656993-9180C1D9-83AD-473C-A63A-88B086C96D24Q43722677-F7F76E24-5C81-491A-A516-765586040B72Q43758513-7C8E2180-CEAC-4880-AF50-3EC6A48054F6Q44364171-4592525A-5124-427A-B8D9-12E1015DCAE9Q44491703-7C4F809D-69AF-49B6-948C-612E4C417050Q44839568-34726495-A166-41FB-B128-B24DEAB4C722Q44908433-44F17030-FEC3-46A2-8D6E-1B8A5D9D0453Q45020128-D36B1CF0-49EF-41C5-B722-8EE6C2A12F58Q45203391-83F8D7FE-33B8-43B3-9DBE-249FD2944A07
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Domenic A Ciraulo
@ast
Domenic A Ciraulo
@en
Domenic A Ciraulo
@es
Domenic A Ciraulo
@nl
Domenic A Ciraulo
@sl
type
label
Domenic A Ciraulo
@ast
Domenic A Ciraulo
@en
Domenic A Ciraulo
@es
Domenic A Ciraulo
@nl
Domenic A Ciraulo
@sl
prefLabel
Domenic A Ciraulo
@ast
Domenic A Ciraulo
@en
Domenic A Ciraulo
@es
Domenic A Ciraulo
@nl
Domenic A Ciraulo
@sl
P1006
P214
P1006
P106
P21
P214
P31
P496
0000-0001-7706-8765
P569
1948-10-14T00:00:00Z
P734
P7859
lccn-n88091318